반응형
GNOM
Genomics & Biotechnology ETF
: High Growth Potential
Genomic sequencing and genetic medicines & therapeutics are helping transform health care in key areas with growing demand, including drug development, precision medicine, and more.
: Structural Tailwinds
The cost of genomic sequencing has dropped from nearly $100mm per genome in 2002 to less than $1,000 in 2020. Adoption has continued to rise, as costs plummet.1
: Targeted Exposure
GNOM provides global exposure to emerging areas within the Health Care sector, at the intersection of science and technology.
상장일 Inception Date: 04/05/19
보수 Gross Expense Ratio: 0.50%
운용규모 Net Assets: $145.10 million
배당 Dividend: N/A
1주당 가격: $14.01
2022-03-15 - 보유 종목 상세 정보
번호 | 구성 종목 비율 | 티커 | 회사명 | 보유 주식수 | 보유 매수금(USD) |
1 | 6.76% | BMRN | 바이오마린 파마슈티컬 | 129,137 | 9,811,829.26 |
2 | 6.43% | SRPT | 사렙타 테라퓨틱스 | 119,842 | 9,329,699.70 |
3 | 5.35% | A | 애질런트 테크놀로지스 | 59,588 | 7,764,912.28 |
4 | 5.25% | QGEN | 퀴아젠 | 173,448 | 7,621,305.12 |
5 | 5.17% | ALNY | 앨나일램 파마슈티컬스 | 48,420 | 7,503,163.20 |
6 | 5.11% | RARE | 울트라제닉스 파마슈티컬 | 113,373 | 7,415,727.93 |
7 | 4.80% | 1548 HK | GENSCRIPT BIOTECH CORP | 2,193,318 | 6,962,425.09 |
8 | 4.23% | CRSP | 크리스퍼 테라퓨틱스 | 99,931 | 6,137,762.02 |
9 | 4.19% | MYGN | 미리아드 제네틱스 | 232,530 | 6,073,683.60 |
10 | 4.16% | VRTX | 버텍스 파마슈티컬 | 25,527 | 6,036,624.96 |
11 | 4.14% | ARWR | 애로우헤드 파마슈티컬스 | 143,603 | 5,999,733.34 |
12 | 3.35% | VCYT | 베라사이트 | 204,209 | 4,858,132.11 |
13 | 3.07% | NSTG | NANOSTRING TECHN | 137,398 | 4,459,939.08 |
14 | 3.02% | NTLA | 인텔리아 테라퓨틱스 | 71,487 | 4,381,438.23 |
번호 | 구성 종목 비율 | 티커 | 회사명 | 보유 주식수 | 보유 매수금(USD) |
15 | 2.91% | CDNA | 케어Dx | 137,311 | 4,226,432.58 |
16 | 2.74% | GILD | 길리어드 사이언스 | 69,323 | 3,970,128.21 |
17 | 2.48% | PACB | 퍼시픽 바이오사이언시스 오브 캘리포니아 | 363,033 | 3,594,026.70 |
18 | 2.35% | ILMN | 일루미나 | 11,201 | 3,403,647.87 |
19 | 2.18% | EDIT | EDITAS MEDICINE INC | 210,445 | 3,169,301.70 |
20 | 2.18% | NTRA | 나테라 | 81,153 | 3,163,343.94 |
21 | 2.17% | RGNX | REGENXBIO INC | 112,170 | 3,153,098.70 |
22 | 2.06% | RCKT | ROCKET PHARMACEU | 190,805 | 2,993,730.45 |
23 | 1.85% | 4974 JP | TAKARA BIO INC | 142,204 | 2,680,113.00 |
24 | 1.73% | NVTA | INVITAE CORP | 344,740 | 2,502,812.40 |
25 | 1.55% | BNTX | 바이오엔테크 SE ADR | 16,609 | 2,252,844.76 |
26 | 1.43% | SGMO | SANGAMO THERAPEUTICS INC | 371,801 | 2,078,367.59 |
27 | 1.30% | SRNE | SORRENTO THERAPEUTICS INC | 864,553 | 1,884,725.54 |
28 | 1.30% | MRNA | 모더나 | 13,595 | 1,878,829.00 |
번호 | 구성 종목 비율 | 티커 | 회사명 | 보유 주식수 | 보유 매수금(USD) |
29 | 1.21% | QURE | UNIQURE NV | 117,230 | 1,759,622.30 |
30 | 1.16% | ALLO | ALLOGENE THERAPEUTICS INC | 205,135 | 1,675,952.95 |
31 | 0.93% | CRBU | CARIBOU BIOSCIENCES INC | 146,144 | 1,343,063.36 |
32 | 0.61% | BLUE | BLUEBIRD BIO INC | 203,075 | 889,468.50 |
33 | 0.56% | TSVT | 2SEVENTY BIO INC | 67,598 | 807,796.10 |
34 | 0.42% | CLLS | CELLECTIS - ADR | 138,533 | 609,545.20 |
35 | 0.41% | DTIL | PRECISION BIOSCIENCES INC | 150,524 | 588,548.84 |
36 | 0.31% | ADVM | ADVERUM BIOTECHN | 346,279 | 446,699.91 |
37 | 0.30% | TCRT | ALAUNOS THERAPEUTICS INC | 594,869 | 436,336.41 |
38 | 0.27% | CASH | 395,858 | 395,846.71 | |
39 | 0.26% | FIXX | HOMOLOGY MEDICINES INC | 118,874 | 375,641.84 |
40 | 0.22% | WVE | WAVE LIFE SCIENCES LTD | 149,657 | 311,286.56 |
41 | 0.10% | PRQR | PROQR THERAPEUTICS NV | 152,137 | 148,211.87 |
댓글